Mibelle Biochemistry: Swiss firm launches new plant stem-cell active PhytoCellTec Alp Rose, derived from alpine roses that grow in extreme conditions - in the snow at altitudes between 2,000 and 3,200 meters - which forces the roses to adapt to cold and ultraviolet exposure. Alp Rose contains stem cells extracted from the rose's leaves, which it says "increase[s] the vitality of skin stem cells" and "helps our skin to cope with [its] compromised barrier because of age and environmental factors." Such environmental factors include temperature changes and UV radiation, Mibelle's Product Manager Elodie Mauger noted at the recent in-cosmetics exhibition in Paris. Mibelle's PhytoCellTech Malus Domestica, a similar active featuring "long-living" stem cells from a rare Swiss apple, is featured in Emerge Labs' Swiss Apple Stem Cell Serum (1"The Rose Sheet" Sept. 29, 2008). Mibelle also offers PhytoCellTec Solar Vitis, a powder based on the stem cells of a markedly UV-tolerant red-flesh grape, it says
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.
FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.
The program would allow early interactions with FDA staff to speed construction and approval of pharmaceutical manufacturing facilities in the US, but will staff be available?
Weaker than expected sales of OTC ED treatment Eroxon has led Futura to launch a review of the brand's future direction.
